In trials where melanotan 1 was administered as an implant, dosages have ranged from 0.08mg/kg to 0.16mg/kg per day for phase I studies
Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder
(For this reason, I love organic crucifers, especially kale, because kales hearty green leaves tend to pick up a lot of toxins from the environment.) Unfortunately, they have gotten a bad rap due to some old nomenclature and outdated patterns in thyroid disease
DSIP is aimed more at sleep depth/quality (slow-wave support)
A practical starting approach is one serving of a sodium-forward electrolyte mixed into water early in the day, then plain water across the rest of the day to a sensible total
There is evidence that insulin under the state of hyperinsulinemia in MASLD can produce ROS (Goldstein et al